Clinical Trials Logo

Clinical Trial Summary

This clinical study will evaluate the clinical performance and the safety of the CE-marked casting and padding materials when used in routine fracture care without any additional invasive methods and within the intended use. As primary objective the cast therapy´s influence on skin microbiome during fracture management will be investigated. Further, the influence of the padding material on the skin microbiome, device comfort, skin conditions, and impact on daily life activities as well as HCP´s and patient´s satisfaction and general product safety and performance are considered as secondary outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05347927
Study type Observational
Source BSN Medical GmbH
Contact Hardy Schweigel, Dr.
Phone +49 152 2775 2954
Email hardy.schweigel@essity.com
Status Recruiting
Phase
Start date October 30, 2022
Completion date August 31, 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT01942577 - Microbiome Survey of Preterm Infants N/A
Active, not recruiting NCT05804851 - Skin Microbiome of Chinese Population Cohort Study
Recruiting NCT04231500 - The Skin Microbiome in Graft Versus Host Disease
Completed NCT04759924 - Mother - Newborn Observational Study
Recruiting NCT04319536 - Integrated Genetic and Functional Analysis of the Female Microbiome in a Flemish Cohort
Completed NCT03605108 - The Influence of Oral Probiotics on the Microbiome and Lipidome N/A
Recruiting NCT05032768 - The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients